Tao Capital Management LP Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001802967 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $1.94B (100.0% shares, 0.0% debt)

Holdings (6)

New Positions (1)

SPCX Space Exploration Technologies Corp. 93.7%

Value $1.819B Shares 10,644,340 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
SPCX	Space Exploration Technologies Corp.	10,644,340	$1.819B	93.7%	—	—	Class A Common Stock	84615Q103

Increased Positions (1)

TXG 10x Genomics, Inc. 0.6%

Value $10.87M (+142.8%) Shares 283,469 (+34.4%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
TXG	10x Genomics, Inc.	283,469 (+34.4%)	$10.87M (+142.8%)	0.6%	—	—	Class A Common Stock	88025U109

Exited Positions (3)

OUST Ouster, Inc. 0.8%

Value $15.53M Shares 845,316 Est. Cost — Unrealized —

MASS 908 Devices Inc. 0.2%

Value $3.482M Shares 568,981 Est. Cost — Unrealized —

WRBY Warby Parker Inc. 0.1%

Value $2.833M Shares 134,473 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
OUST	Ouster, Inc.	845,316	$15.53M	0.8%	—	—	—	68989M202
MASS	908 Devices Inc.	568,981	$3.482M	0.2%	—	—	—	65443P102
WRBY	Warby Parker Inc.	134,473	$2.833M	0.1%	—	—	—	93403J106

Decreased Positions (1)

TWST Twist Bioscience Corporation 2.5%

Value $49.26M (+25.1%) Shares 478,815 (-42.2%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
TWST	Twist Bioscience Corporation	478,815 (-42.2%)	$49.26M (+25.1%)	2.5%	—	—	Common Stock	90184D100

Unchanged Positions (3)

TSLA Tesla, Inc. 1.9%

Value $36.28M Shares 86,250 Est. Cost — Unrealized —

H Hyatt Hotels Corporation 0.7%

Value $13.57M Shares 70,000 Est. Cost — Unrealized —

MDGL Madrigal Pharmaceuticals, Inc. 0.6%

Value $11.28M Shares 21,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
TSLA	Tesla, Inc.	86,250	$36.28M	1.9%	—	—	Common Stock	88160R101
H	Hyatt Hotels Corporation	70,000	$13.57M	0.7%	—	—	Class B Common Stock	448579102
MDGL	Madrigal Pharmaceuticals, Inc.	21,000	$11.28M	0.6%	—	—	Common Stock	558868105